34 Grants (Page 1 of 2)
2022
IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
Paczesny, Sophie
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL158096-01A1), $625,635USD, 2022-01-01 -- 2025-12-31
 
Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease
Logan, Brent R and Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA264921-01A1), $628,188USD, 2021-12-02 -- 2026-11-30
2021
Cancer Immunology
Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA138313-13-7343), $43,932USD, 2009-04-01 -- 2024-03-31
 
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
Paczesny, Sophie and YANG, CHAO-YIE
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL141432-04), $636,111USD, 2019-06-06 -- 2023-01-31
 
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA168814-07), $323,667USD, 2013-05-03 -- 2025-04-30
2020
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
Paczesny, Sophie and YANG, CHAO-YIE
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL141432-03), $650,311USD, 2019-06-06 -- 2023-01-31
 
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
CHEUNG, NAI-KONG V and Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3U01CA232491-02S1), $153,053USD, 2020-08-06 -- 2021-07-31
 
Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation
Paczesny, Sophie
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5P50HD090215-05-8543), $202,258USD, 2020
 
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA168814-06A1), $345,428USD, 2013-05-03 -- 2025-04-30
2019
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
Paczesny, Sophie and YANG, CHAO-YIE
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7R01HL141432-02), $641,835USD, 06/06/2019 -- 01/31/2023
 
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
Paczesny, Sophie and YANG, CHAO-YIE
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL141432-01A1), $703,200USD, 02/01/2019 -- 01/31/2023
 
Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation
Paczesny, Sophie
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5U54HD090215-04-8543), $202,258USD, 2019
2018
Biomarkers for risk of chronic Graft-Versus-Host Disease occurrence
Paczesny, Sophie
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R21HL139934-02), $117,429USD, 09/12/2017 -- 08/31/2019
 
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
CHEUNG, NAI-KONG V and Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1U01CA232491-01), $4,129,375USD, 09/14/2018 -- 06/30/2023
 
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
CHEUNG, NAI-KONG V and Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7U01CA232491-02), $2,940,474USD, 2018-09-14 -- 2023-06-30
 
Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation
Paczesny, Sophie
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5U54HD090215-03-8543), $213,321USD, 2018
2017
Biomarkers for risk of chronic Graft-Versus-Host Disease occurrence
Paczesny, Sophie
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R21HL139934-01), $131,813USD, 09/12/2017 -- 08/31/2019
 
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease
Paczesny, Sophie and Renbarger, Jamie L
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R01HD074587-05), $491,398USD, 08/01/2013 -- 05/31/2018
 
Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation
Paczesny, Sophie
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5U54HD090215-02-8543), $213,258USD, 2017
 
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA168814-05), $69,085USD, 05/03/2013 -- 04/30/2018
2016
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease
Paczesny, Sophie ( and Renbarger, Jamie L
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 4R01HD074587-04), $505,765USD, 08/01/2013 -- 05/31/2018
 
Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation
Paczesny, Sophie
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 1U54HD090215-01-8543), $255,554USD, 2016
 
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
Paczesny, Sophie
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 4R01CA168814-04), $324,148USD, 05/03/2013 -- 04/30/2018
2015
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease
Paczesny, Sophie ( and Renbarger, Jamie L
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 5R01HD074587-03), $458,943USD, 08/01/2013 -- 05/31/2018
 
High Throughput Screening (HTS) to Discover Graft-Versus-Host Disease Inhibitors
Paczesny, Sophie ( and YANG, CHAO-YIE
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA174667-03), $323,596USD, 04/08/2013 -- 03/31/2016